Stockscreener 앱 받기
0.69
8.40%
-0.0633
시장 영업 전:
.67
-0.02
-2.90%
Prokidney Corp 주식(PROK)의 최신 뉴스
ProKidney Corp. (NASDAQ:PROK) Shares Bought by Renaissance Technologies LLC - Defense World
JPMorgan Chase & Co. Buys 19,585 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney (PROK) Expected to Announce Quarterly Earnings on Friday - Defense World
The ProKidney Corp (PROK) had a good session last reading, didn’t it? - uspostnews.com
ProKidney Corp (PROK) receives a Neutral rating from JP Morgan - knoxdaily.com
ProKidney Corp Inc. (PROK) Price Performance: The Role of Supply and Demand - investchronicle.com
Gaining Ground: ProKidney Corp (PROK) Closes Higher at 1.08, Up 4.85 - DWinneX
Geode Capital Management LLC Grows Stock Position in ProKidney Corp. (NASDAQ:PROK) - Defense World
Is ProKidney Corp (PROK) positioned for future growth? - Sete News
ProKidney Corp (NASDAQ:PROK)’s 12-Month Price Target Currently Stands At 6 - Marketing Sentinel
Major Investment Alert: Carso De-C Inmobiliaria Acquires ProKidney Shares! - TipRanks
ProKidney Corp [PROK] Records 50-Day SMA of $1.0283 - knoxdaily.com
The Psychology of ProKidney Corp Inc. (PROK) Price Performance: Understanding Market Sentiment - investchronicle.com
Analytical Overview: ProKidney Corp (PROK)’s Ratios Tell a Financial Story - DWinneX
Major Investment Alert: ProKidney Stock Sees New Stakeholder! - TipRanks
Major Investment Alert: ProKidney Stock Acquisition! - TipRanks
Major Investment Alert: ProKidney Stock Sees Significant Purchase! - TipRanks
Greensboro’s Once Great Win Is Now A ProKidney Failure - The Rhino Times of Greensboro -
Major Investment Alert: ProKidney Stock Sees Big Buy-In! - TipRanks
Control empresarial de capitales purchases $628,847 in ProKidney shares - Investing.com
Control empresarial de capitales purchases $628,847 in ProKidney shares By Investing.com - Investing.com Canada
Sei Investments Co. Makes New $69,000 Investment in ProKidney Corp. (NASDAQ:PROK) - Defense World
Critical Review: Candel Therapeutics (NASDAQ:CADL) & ProKidney (NASDAQ:PROK) - Defense World
PROK stock touches 52-week low at $0.49 amid market challenges - Investing.com India
Institutional owners may take dramatic actions as ProKidney Corp.'s (NASDAQ:PROK) recent 32% drop adds to one-year losses - simplywall.st
Bank of New York Mellon Corp Has $388,000 Holdings in ProKidney Corp. (NASDAQ:PROK) - Defense World
Here's Why We're Watching ProKidney's (NASDAQ:PROK) Cash Burn Situation - Yahoo Finance
Down -38% in 4 Weeks, Here's Why You Should You Buy the Dip in PROKIDNEY CP (PROK) - Yahoo Finance
PROK stock touches 52-week low at $0.94 amid market challenges - Investing.com India
ProKidney Corp reports results for the quarter ended December 31Earnings Summary - TradingView
ProKidney Hold Rating: Balancing Developmental Progress and Financial Stability Amid Uncertainty - TipRanks
ProKidney Corp (PROK) Reports $163.3 Million Net Loss for 2024, - GuruFocus.com
ProKidney reports larger loss in 2024 as production resumes - Winston-Salem Journal
PROKIDNEY CORP. SEC 10-K Report - TradingView
ProKidney CEO cites 'significant progress' after regenerative medicine company loses $163M in 2024 - The Business Journals
ProKidney reports FY24 EPS (62c), consensus (59c) - TipRanks
ProKidney Corp. Reports 2024 Financial Results and Milestones in Rilparencel Development for Chronic Kidney Disease - Nasdaq
ProKidney Reports Full Year 2024 Financial Results and Business Highlights - GlobeNewswire
FDA Fast-Tracks ProKidney's CKD Treatment: $358M War Chest Fuels Breakthrough Development - StockTitan
PROKProKidney Latest Stock News & Market Updates - Stock Titan
Top 3 Health Care Stocks You'll Regret Missing This Quarter - Benzinga
ProKidney (PROK) Expected to Announce Quarterly Earnings on Thursday - Defense World
ProKidney (NASDAQ:PROK) Stock Price Down 2.7%Here's What Happened - MarketBeat
ProKidney stock hits 52-week low at $1.34 amid market challenges - Investing.com Australia
ProKidney stock hits 52-week low at $1.34 amid market challenges By Investing.com - Investing.com South Africa
Head to Head Review: ProKidney (NASDAQ:PROK) and Adaptimmune Therapeutics (NASDAQ:ADAP) - Defense World
Owning 32% shares,institutional owners seem interested in ProKidney Corp. (NASDAQ:PROK), - Yahoo
ProKidney Corp (NASDAQ: PROK) Has Great Upside Potential - Stocks Register
ProKidney Corp [PROK] Chief Regulatory Officer makes an insider sale of 16,412 shares worth 41,030. - Knox Daily
5.24%
자본화:
|
볼륨(24시간):